Some aspects of the in vivo neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship.
about
ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease.The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in miceDietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins.Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.Dietary Polyphenol Supplementation Prevents Alterations of Spatial Navigation in Middle-Aged Mice.Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic moleculesModulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin.Phytochemicals in Ischemic Stroke.Fisetin and Its Role in Chronic Diseases.NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives.Green tea polyphenols attenuate glial swelling and mitochondrial dysfunction following oxygen-glucose deprivation in cultures.A novel approach to screening for new neuroprotective compounds for the treatment of stroke.Cytoprotective effects of fisetin against hypoxia-induced cell death in PC12 cells.The effects of fisetin on lipopolysaccharide-induced depressive-like behavior in mice.Quercetin Prevents Body Weight Loss Due to the Using of Superparamagnetic Iron Oxide Nanoparticles in Rat.Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain
P2860
Q34424253-5AE61933-A83B-4284-B65D-541A2EDC51B1Q35939184-01AA3946-C165-49C6-894A-61D33C6B9498Q36237752-2CAE444C-F4E3-4212-A08D-A77676DAF258Q36534389-4E400045-AFA5-44B0-9121-8186DB71B019Q36559195-5BCF4978-2798-4742-9625-B5BCA73AD2A0Q36841904-178BF2A9-FB0C-46F5-AEC5-4864EA5A062AQ37418045-BA930EB7-28B9-4094-9AB3-6DE40C7A8AFCQ38837831-DA265409-F37D-4BED-A76D-8DDBA817D381Q38965216-C2887DEF-4F16-48F0-A26C-9E3EB7B400D6Q39496194-7C17A181-E24F-4D6F-8D68-8ADBE3AE6760Q39862749-51DB7BFD-3958-46C5-ABFE-D8E376A3310DQ40086328-4E32B258-FD09-42AF-A28D-FB2A694E0600Q42703535-DDC3E58F-6493-4B89-B785-ABD4CAD0C484Q48054779-2FD9259A-9778-4E87-80ED-8CC7ED70F20CQ49866076-60BEEA01-6787-4FD8-AA99-776D9258BDC2Q58698278-F3E7C875-1207-46B8-8B5B-EA0A1713EADE
P2860
Some aspects of the in vivo neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Some aspects of the in vivo ne ...... ructure-activity relationship.
@en
Some aspects of the in vivo ne ...... ructure-activity relationship.
@nl
type
label
Some aspects of the in vivo ne ...... ructure-activity relationship.
@en
Some aspects of the in vivo ne ...... ructure-activity relationship.
@nl
prefLabel
Some aspects of the in vivo ne ...... ructure-activity relationship.
@en
Some aspects of the in vivo ne ...... ructure-activity relationship.
@nl
P2093
P2860
P356
P1476
Some aspects of the in vivo ne ...... ructure-activity relationship.
@en
P2093
Andrea Morquio
Elena Gervaz
Federico Dajas
Felicia Rivera
Jessika Urbanavicius
P2860
P2888
P304
P356
10.1007/BF03033450
P577
2004-01-01T00:00:00Z
P6179
1029370766